{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:13:43Z","timestamp":1791112423428,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/fpc.0b013e32814db8b7","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T13:56:41Z","timestamp":1236175001000},"page":"755-764","source":"Crossref","is-referenced-by-count":66,"title":["Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy"],"prefix":"10.1097","volume":"17","author":[{"given":"Mireia","family":"Arnedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Taff\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansjakob","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hirschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Elzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Vernazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enos","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Darioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques S.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalio","family":"Telenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Tarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210212","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-8-20210212","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","article-title":"Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group","volume":"37","author":"Dube","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R3-8-20210212","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1517\/14656566.6.10.1619","article-title":"Treatment of dyslipidaemia in HIV-infected persons","volume":"6","author":"Manuel","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"R4-8-20210212","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-8-20210212","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?","volume":"189","author":"Fontas","year":"2004","journal-title":"J Infect Dis"},{"key":"R7-8-20210212","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study","volume":"100","author":"Periard","year":"1999","journal-title":"Circulation"},{"key":"R8-8-20210212","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00042560-200104010-00018","article-title":"Persistent dyslipidemia in HIV-infected individuals switched from a protease inhibitor-containing to an efavirenz-containing regimen","volume":"26","author":"Doser","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-8-20210212","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJMoa021589","article-title":"Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection","volume":"349","author":"Martinez","year":"2003","journal-title":"N Engl J Med"},{"key":"R10-8-20210212","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/135965350501000511","article-title":"Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study","volume":"10","author":"Young","year":"2005","journal-title":"Antivir Ther"},{"key":"R11-8-20210212","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R12-8-20210212","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1371\/journal.pmed.0010019","article-title":"Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1","volume":"1","author":"van Leth","year":"2004","journal-title":"PLoS Med"},{"key":"R13-8-20210212","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/429295","article-title":"Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders","volume":"191","author":"Tarr","year":"2005","journal-title":"J Infect Dis"},{"key":"R14-8-20210212","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"R15-8-20210212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00002030-200501280-00007","article-title":"Atazanavir plus ritonavir or saquinavir, and lopinavir\/ritonavir in patients experiencing multiple virological failures","volume":"19","author":"Johnson","year":"2005","journal-title":"AIDS"},{"key":"R16-8-20210212","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0140-6736(01)06413-3","article-title":"Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study","volume":"358","author":"Fellay","year":"2001","journal-title":"Lancet"},{"key":"R17-8-20210212","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddi251","article-title":"Guidelines for association studies in Human Molecular Genetics","volume":"14","author":"Freimer","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R18-8-20210212","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"R19-8-20210212","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2307\/2531727","article-title":"An approach to the analysis of repeated measurements","volume":"44","author":"Diggle","year":"1988","journal-title":"Biometrics"},{"key":"R20-8-20210212","article-title":"Analysis of longitudinal data. 2nd edition","author":"Diggle","year":"2002"},{"key":"R21-8-20210212","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/096228029200100302","article-title":"Longitudinal studies with continuous responses","volume":"1","author":"Laird","year":"1992","journal-title":"Stat Meth Med Res"},{"key":"R22-8-20210212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2307\/2532504","article-title":"Unequally spaced longitudinal data with AR(1) serial correlation","volume":"47","author":"Jones","year":"1991","journal-title":"Biometrics"},{"key":"R23-8-20210212","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/01621459.1989.10478790","article-title":"Model for longitudinal data with random effects and AR(1) errors","volume":"84","author":"Chi","year":"1989","journal-title":"J Am Stat Societ"},{"key":"R24-8-20210212","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2307\/3109751","article-title":"Nonparametric estimation of covariance structure in longitudinal data","volume":"54","author":"Diggle","year":"1998","journal-title":"Biometrics"},{"key":"R25-8-20210212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects","volume":"14","author":"Purnell","year":"2000","journal-title":"AIDS"},{"key":"R26-8-20210212","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/oxfordjournals.aje.a115710","article-title":"Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults","volume":"132","author":"Ware","year":"1990","journal-title":"Am J Epidemiol"},{"key":"R27-8-20210212","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/28.5.964","article-title":"The use of fractional polynomials to model continuous risk variables in epidemiology","volume":"28","author":"Royston","year":"1999","journal-title":"Int J Epidemiol"},{"key":"R28-8-20210212","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/jmps.1999.1276","article-title":"An introduction to model selection","volume":"44","author":"Zucchini","year":"2000","journal-title":"J Math Psychol"},{"key":"R29-8-20210212","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/03610919808813505","article-title":"Methods of variable selection in regression modelling","volume":"27","author":"Murtaugh","year":"1998","journal-title":"Commun Statist: Simul Comput"},{"key":"R30-8-20210212","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/00031305.1990.10475712","article-title":"Multiple comparison procedures: the practical solution","volume":"44","author":"Saville","year":"1990","journal-title":"Am Statist"},{"key":"R31-8-20210212","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1523-1739.2005.00269.x","article-title":"Judicious use of multiple hypothesis tests","volume":"19","author":"Roback","year":"2003","journal-title":"Conserv Biol"},{"key":"R32-8-20210212","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-1765(03)00032-6","article-title":"Interaction terms in logit and probit models","volume":"80","author":"Chunrong","year":"2003","journal-title":"Econ Lett"},{"key":"R33-8-20210212","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/01.ede.0000129508.82783.94","article-title":"Assessing interaction in case-control studies: type I errors when using both additive and multiplicative scales","volume":"15","author":"Starr","year":"2004","journal-title":"Epidemiology"},{"key":"R35-8-20210212","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/00002030-200112070-00007","article-title":"An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride\/low HDL levels in treated HIV patients","volume":"15","author":"Fauvel","year":"2001","journal-title":"AIDS"},{"key":"R36-8-20210212","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1093\/hmg\/11.24.3031","article-title":"Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels","volume":"11","author":"Pennacchio","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R37-8-20210212","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/hmg\/11.24.3039","article-title":"Relative contribution of variation within the APOC3\/A4\/A5 gene cluster in determining plasma triglycerides","volume":"11","author":"Talmud","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R38-8-20210212","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/01.ATV.20.2.507","article-title":"New functional promoter polymorphism, CETP\/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1\/Sp3 in transcriptional regulation","volume":"20","author":"Dachet","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R39-8-20210212","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng749","article-title":"Replication validity of genetic association studies","volume":"29","author":"Ioannidis","year":"2001","journal-title":"Nat Genet"},{"key":"R40-8-20210212","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(03)12715-8","article-title":"Problems of reporting genetic associations with complex outcomes","volume":"361","author":"Colhoun","year":"2003","journal-title":"Lancet"},{"key":"R41-8-20210212","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pmed.0030052","article-title":"Associations among race\/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy","volume":"3","author":"Foulkes","year":"2006","journal-title":"PLoS Med"},{"key":"R42-8-20210212","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajmg.10445","article-title":"Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia","volume":"110","author":"Han","year":"2002","journal-title":"Am J Med Genet"},{"key":"R43-8-20210212","doi-asserted-by":"crossref","first-page":"582","DOI":"10.7326\/0003-4819-136-8-200204160-00007","article-title":"High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study","volume":"136","author":"Rodondi","year":"2002","journal-title":"Ann Intern Med"},{"key":"R44-8-20210212","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng853","article-title":"Polygenic susceptibility to breast cancer and implications for prevention","volume":"31","author":"Pharoah","year":"2002","journal-title":"Nat Genet"},{"key":"R45-8-20210212","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/382052","article-title":"Revisiting the clinical validity of multiplex genetic testing in complex diseases","volume":"74","author":"Janssens","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R46-8-20210212","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1371\/journal.pmed.0030374","article-title":"Combining information from common type 2 diabetes risk polymorphisms improves disease prediction","volume":"3","author":"Weedon","year":"2006","journal-title":"PLoS Med"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01213011-200709000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:41:48Z","timestamp":1786038108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-200709000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32814db8b7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1097223.553233","asserted-by":"object"}]},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}